-transparent.png){kind=logo}
L-5-alpha-hydroxypropionylamino-2,4,6-triiodoisophthalic acid di-(1,3-dihydroxy-2-propylamide), abbreviated Iopamidol, a new non-ionic water soluble contrast agent for angiography, myelography, ventriculography and for contrast reinforced computer-assisted axial tomography is described. Extensive preclinical testing showed favorable physico-chemical features of the new compound, low systemic toxicity, excellent cardiovascular and renal tolerability, very mild effects on the blood-brain barrier and on nervous tissue.
Related Publications
E Felder, and
D Pitrè, and
P Tirone
December 1973,
Il Farmaco; edizione scientifica,
E Felder, and
D Pitrè, and
P Tirone
September 1981,
Radiology,
E Felder, and
D Pitrè, and
P Tirone
August 1994,
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes,
E Felder, and
D Pitrè, and
P Tirone
August 1967,
Oral surgery, oral medicine, and oral pathology,
E Felder, and
D Pitrè, and
P Tirone
June 1976,
Il Farmaco; edizione scientifica,
E Felder, and
D Pitrè, and
P Tirone
November 1973,
Il Farmaco; edizione scientifica,
E Felder, and
D Pitrè, and
P Tirone
January 1972,
Review of surgery,
E Felder, and
D Pitrè, and
P Tirone
October 1989,
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
E Felder, and
D Pitrè, and
P Tirone
May 1989,
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
E Felder, and
D Pitrè, and
P Tirone
December 1998,
Allergy,
